Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rahimeh Emamnejad"'
Autor:
Rahimeh Emamnejad, Mary Dass, Michael Mahlis, Salome Bozkurt, Sining Ye, Maurice Pagnin, Paschalis Theotokis, Nikolaos Grigoriadis, Steven Petratos
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Multiple sclerosis (MS) is a heterogeneous autoimmune disease whereby the pathological sequelae evolve from oligodendrocytes (OLs) within the central nervous system and are targeted by the immune system, which causes widespread white matter pathology
Externí odkaz:
https://doaj.org/article/16603ae7026e485798941b8717bb479e
Autor:
Bahare Laribi, Mohammad Ali Sahraian, Mehdi Shekarabi, Rahimeh Emamnejad, Mohsen Marzban, Shokufeh Sadaghiani, Maryam Izad
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 17, Iss 4 (2018)
Fingolimod is a novel immunomodulatory drug used in patients with relapsing multiple sclerosis (MS) which reversibly inhibits egress of lymphocytes from lymph nodes. In this longitudinal study, the frequency of Interferon- gamma (IFN-γ)+, IL4+, IL17
Externí odkaz:
https://doaj.org/article/c87989d22b25434fba6986471264eef6
Autor:
Nima Rezaei, Danyal Imani, Zahra Salehi, Maryam Izad, Amirreza Azimi, Rahimeh Emamnejad, Maryam Sadr
Publikováno v:
International Journal of Immunogenetics. 45:329-336
Nod-like receptor protein 3 (NLRP3) inflammasome is a multi-protein complex that controls the production of pro-inflammatory cytokines, IL-18 and IL-1β, through caspase-1 activation. These inflammatory cytokines play an important role in the develop
Autor:
Zahra Salehi, Hedayatollah Shirzad, Maryam Izad, Mohammad Ali Sahraian, Rahimeh Emamnejad, Danyal Imani, Yadollah Shakiba, Bahareh Laribi, Ahmad Masoomi, Farangis Najafi
Publikováno v:
Multiple sclerosis and related disorders. 35
Background Mesenchymal stem cells (MSCs) have the capacity to migrate into the inflammatory regions in response to chemokines such as, IP-10 and SDF-1α and function as anti-inflammatory and immunomodulatory cells. Methods In this study we investigat